The Chamber Bench of the Supreme Court upheld an order of the High Court banning production and sale of substandard antibiotic (penicillin and cephalosporin-group) and anti-cancer drugs of 28 pharmaceutical companies.
The 28 companies are Amico Pharma, Aztec Pharmaceuticals, Bengal Techno Pharma Ltd, Benham Pharmaceuticals, Central Pharmaceuticals, Descent Pharma, Dr Tims Pharmaceuticals, Globex Pharmaceuticals, Greenland Pharmaceuticals, Inova Pharmaceuticals, Max Drugs Ltd, Medi Mate Laboratories, Modern Pharmaceuticals, Mystic Pharmaceuticals, National Laboratories, Organic Health Care Ltd, Wester Pharma, Premier Pharmaceuticals, Prime Pharmaceuticals, Seema Pharmaceuticals, White Horse Pharmaceuticals, Momtaz Pharmaceuticals, Unique Pharmaceuticals, United Chemicals and Pharmaceuticals, FNF Pharmaceuticals, Techo Drugs Limited's Units 1,2 and 3.
Chamber Judge Hasan Foez Siddique passed the order on Thursday, rejecting a petition filed by an aggrieved company.
On April 3, the High Court upheld its previous order directing 28 drug companies to stop production and sale of antibiotic (penicillin and cephalosporin-group) and anti-cancer drugs.
A division bench comprising Justice Mohammad Dastagir Hossain and Justice Md Ataur Rahman Khan passed the order.
On February 27, after a hearing on a petition filed by Human Rights and Peace for Bangladesh (HRPB), the same HC bench issued a rule asking the government to explain as to why production of the 28 drug companies shall not be banned.
Lawyer and president of HRPB Manzil Murshid said the court also directed the drug administration to form a five-member expert committee within 15 days to monitor whether drug companies have been following Good Manufacturing Practice (GMP) set by the World Health Organisation (WHO) or not.
The GMP ensures quality standard for production and sale of all medical products..